Medpace Holdings

MEDP · NASDAQ · USD

598,08 $Veränderung zum vorherigen Schlusskurs: −4,18 %Absolute Veränderung: −26,10 $

Schlusskurs · 1. Oktober 2026

Unternehmensprofil

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Beschreibung auf Englisch verfügbar.

Unternehmensdaten

Branche
Gesundheit
Industrie
Diagnostics & Research
Hauptsitz
5375 Medpace Way, 45227, Cincinnati
Mitarbeitende
6.500
Notierung
MEDP · NASDAQ
Währung
USD